Price T Rowe Associates Inc Ideaya Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,904,916 shares of IDYA stock, worth $44.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,904,916
Previous 3,475,622 45.19%
Holding current value
$44.9 Million
Previous $56.9 Million 29.66%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$14.5 - $22.63 $22.8 Million - $35.5 Million
-1,570,706 Reduced 45.19%
1,904,916 $40 Million
Q1 2025

May 14, 2025
SELL
$16.38 - $26.0 $6.41 Million - $10.2 Million
-391,286 Reduced 10.12%
3,475,622 $56.9 Million
Q4 2024

Feb 14, 2025
SELL
$24.79 - $31.98 $3.68 Million - $4.75 Million
-148,390 Reduced 3.7%
3,866,908 $99.4 Million
Q3 2024

Nov 14, 2024
BUY
$30.37 - $43.05 $8.25 Million - $11.7 Million
271,557 Added 7.25%
4,015,298 $127 Million
Q2 2024

Aug 14, 2024
SELL
$34.37 - $43.46 $10.6 Million - $13.4 Million
-308,759 Reduced 7.62%
3,743,741 $131 Million
Q1 2024

May 15, 2024
BUY
$34.2 - $47.13 $16.6 Million - $22.9 Million
486,222 Added 13.63%
4,052,500 $178 Million
Q4 2023

Feb 14, 2024
BUY
$24.59 - $35.83 $13.2 Million - $19.2 Million
535,909 Added 17.68%
3,566,278 $127 Million
Q3 2023

Nov 14, 2023
BUY
$21.07 - $29.77 $11.1 Million - $15.7 Million
527,696 Added 21.09%
3,030,369 $81.8 Million
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $13.8 Million - $26.5 Million
1,036,086 Added 70.65%
2,502,673 $58.8 Million
Q1 2023

May 15, 2023
SELL
$13.49 - $18.72 $2.66 Million - $3.69 Million
-196,941 Reduced 11.84%
1,466,587 $20.1 Million
Q4 2022

Feb 14, 2023
SELL
$14.47 - $18.17 $2.83 Million - $3.55 Million
-195,349 Reduced 10.51%
1,663,528 $30.2 Million
Q3 2022

Nov 14, 2022
SELL
$9.24 - $15.79 $252,945 - $432,251
-27,375 Reduced 1.45%
1,858,877 $27.7 Million
Q2 2022

Aug 15, 2022
SELL
$8.28 - $13.88 $1.89 Million - $3.17 Million
-228,741 Reduced 10.82%
1,886,252 $26 Million
Q1 2022

May 16, 2022
SELL
$11.18 - $24.02 $6.56 Million - $14.1 Million
-586,532 Reduced 21.71%
2,114,993 $23.7 Million
Q4 2021

Feb 14, 2022
BUY
$20.95 - $26.88 $7.66 Million - $9.83 Million
365,619 Added 15.65%
2,701,525 $63.9 Million
Q3 2021

Nov 15, 2021
BUY
$17.26 - $27.08 $17.7 Million - $27.8 Million
1,025,929 Added 78.32%
2,335,906 $59.5 Million
Q2 2021

Aug 16, 2021
BUY
$17.76 - $24.83 $7.28 Million - $10.2 Million
409,712 Added 45.51%
1,309,977 $27.5 Million
Q1 2021

May 17, 2021
BUY
$13.48 - $23.77 $5.79 Million - $10.2 Million
429,166 Added 91.1%
900,265 $21.2 Million
Q4 2020

Feb 16, 2021
BUY
$12.17 - $17.52 $5.73 Million - $8.25 Million
471,099 New
471,099 $6.6 Million

Others Institutions Holding IDYA

# of Institutions
218
Shares Held
83.4M
Call Options Held
28.7K
Put Options Held
132K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.13B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email